Patents by Inventor Bo E. Hedlund

Bo E. Hedlund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6780852
    Abstract: The invention relates to polysaccharides, polysaccharide conjugates and complexes with altered biological properties, and methods to produce these polysaccharides, polysaccharide conjugates and complexes.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: August 24, 2004
    Inventors: Bo E. Hedlund, Thomas P. Weber, Paul R. Dragsten, Gregory J. Hanson, Philip E. Hallaway
  • Publication number: 20030236224
    Abstract: The invention relates to polysaccharides, polysaccharide conjugates and polysaccharide complexes with altered biological properties, methods to produce these polysaccharides, polysaccharide conjugates and polysaccharide complexes and methods to use these conjugates and complexes in the treatment of iron overload or iron deficiency diseases.
    Type: Application
    Filed: May 1, 2003
    Publication date: December 25, 2003
    Inventors: Bo E. Hedlund, Thomas P. Weber, Paul R. Dragsten, Gregory J. Hanson, Philip E. Hallaway
  • Publication number: 20030153531
    Abstract: The invention relates to polysaccharides, polysaccharide conjugates and complexes with altered biological properties, and methods to produce these polysaccharides, polysaccharide conjugates and complexes.
    Type: Application
    Filed: November 12, 2002
    Publication date: August 14, 2003
    Inventors: Bo E. Hedlund, Thomas P. Weber, Paul R. Dragsten, Gregory J. Hanson, Philip E. Hallaway
  • Patent number: 6479468
    Abstract: The invention relates to polysaccharides, polysaccharide conjugates with altered biological properties, and methods to produce these polysaccharides and conjugates.
    Type: Grant
    Filed: August 1, 2000
    Date of Patent: November 12, 2002
    Assignee: Biomedical Frontiers, Inc.
    Inventors: Bo E. Hedlund, Thomas P. Weber, Paul R. Dragsten, Gregory J. Hanson, Philip E. Hallaway
  • Patent number: 5416078
    Abstract: The invention relates to fluid resuscitation of the human or animal body by administration of deferoxamine (DFO) and a water-soluble biopolymer.The DFO and the biopolymer are preferably bonded together.The biopolymer may be a polysaccharide or a protein.The DFO and the biopolymer are preferably formulated as an aqueous solution suitable for oral administration.The fluid resuscitation may be effected for ameliorating systemic oxidant injury occurring during ischemia and subsequent reperfusion.The fluid resuscitation may be indicated in treatment of burn injury, lung injury caused by inhalation of hot and/or toxic substances, such as smoke derived from combustion, hemorrhagic shock and other types of trauma.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: May 16, 1995
    Assignee: Biomedical Frontiers, Inc.
    Inventors: Bo E. Hedlund, Philip E. Hallaway
  • Patent number: 5268165
    Abstract: Compositions comprising a covalently bounded adduct of deferoxamine, ferric iron and polymer for image enhancement in magnetic resonance (MR) imaging are provided. A pharmaceutical composition comprising the adduct and method of using the composition in magnetic resonance imaging are also disclosed.
    Type: Grant
    Filed: August 7, 1992
    Date of Patent: December 7, 1993
    Assignee: Biomedical Frontiers, Inc.
    Inventors: Bo E. Hedlund, Philip E. Hallaway
  • Patent number: 5217998
    Abstract: A method for scavenging free iron or aluminum in fluids such as physiological fluids involves a provision in such fluids of a soluble polymer substrate having chelator immobilized thereon. According to the invention preferred such compounds comprise polysaccharides or proteins having a deferoxamine moiety thereon. Such a compound can be used for the treatment of iron overload, as well as to inhibit cell damage from oxidation/reduction reactions. In one embodiment, cell damage during reperfusion is inhibited, through provision of the chelating moiety at the site of reperfusion.
    Type: Grant
    Filed: June 17, 1991
    Date of Patent: June 8, 1993
    Assignee: Biomedical Frontiers, Inc.
    Inventors: Bo E. Hedlund, Philip E. Hallaway, Samuel S. Panter, John W. Eaton
  • Patent number: 4863964
    Abstract: A method for scavenging free iron or aluminum in fluids such as physiological fluids involves a provision in such fluids of a soluble polymer substrate having chelator immobilized thereon. According to the invention preferred such compounds comprise polysaccarides or proteins having a deferoxamine moiety thereon. Such a compound can be used for the treatment of iron overload, as well as to inhibit cell damage from oxidation/reduction reactions. In one embodiment, cell damage during reperfusion is inhibited, through provision of the chelating moiety at the site of reperfusion.
    Type: Grant
    Filed: August 20, 1987
    Date of Patent: September 5, 1989
    Assignee: Biomedical Frontiers, Inc.
    Inventors: Bo E. Hedlund, Philip E. Hallaway, Samuel S. Panter, John W. Eaton